BIT Chart, page-360

My question is why buy before asking the wife? It seems way too many people failed to do basic research before investing in Biotron and are now suffering the consequences. I have noticed that there has been a plethora of ill informed commentary centred around results and options over the last few days. Had investors read prior to jumping on the bandwagon, they may have saved themselves from short term pain. Biotechs are always a long term investment, riding the waves up and down over the course of clinical trials. While I’m pleased with the latest announcement (and SP rise), it is entirely unclear as to whether BIT225 is the magic bullet, and if/when this goes to Phase III, it has every chance to fail, like so many Phase III trials before it. Having said that, it could turn out to play an adjunctive role in the eradication of HIV amongst other viruses, but only time and money will tell.